{
    "id": 29591,
    "fullName": "SOAT1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "SOAT1 over exp indicates an over expression of the Soat1 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 6646,
        "geneSymbol": "SOAT1",
        "terms": [
            "SOAT1",
            "ACACT",
            "ACAT",
            "ACAT-1",
            "ACAT1",
            "SOAT",
            "STAT"
        ]
    },
    "variant": "over exp",
    "createDate": "03/27/2019",
    "updateDate": "03/27/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16554,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Avasimibe inhibited tumor growth in hepatocellular carcinoma patient-derived xenograft (PDX) models with high SOAT1 expression (PMID: 30814741).",
            "molecularProfile": {
                "id": 31663,
                "profileName": "SOAT1 over exp"
            },
            "therapy": {
                "id": 8102,
                "therapyName": "Avasimibe",
                "synonyms": null
            },
            "indication": {
                "id": 684,
                "name": "hepatocellular carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14617,
                    "pubMedId": 30814741,
                    "title": "Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30814741"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31663,
            "profileName": "SOAT1 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}